DiGeorge`s syndrome
Download
Report
Transcript DiGeorge`s syndrome
Pathophysiology of
Immunodeficiency Diseases
Host Defense Mechanisms
•
•
•
•
•
Skin and mucosal barriers
Humoral immunity (B cells, plasma cells, Ab)
Cell-mediated immunity (T cells)
Phagocytosis
Complement
Overview of
Immunodeficiency
Disorders.
The defect might be
In the level of
stem cell
or
in any other
level of tree
Introduction.
• Immunodeficiency diseases are :
A diverse spectrum of illnesses due to various
abnormalities of the immune system
• Prevalence :
Primary (congenital) 1 : 10,000 to 1 : 200,000
present at birth .
Secondary (acquired) is more common .
Origins of Immunodeficiency
o Primary or Congenital
Inherited genetic defects in immune cell
development or function, or inherited deficiency in
a particular immune component
o Secondary or acquired
A loss of previously functional immunity due
to infection, toxicity, radiation, splenectomy,
aging, malnutrition, etc.
Primary or acquired.
can affect.
Natural immunity
(non-specific body defenses).
Phagocytic
cells.
Complement
proteins.
Acquired immunity.
(specific body defenses).
T-cells.
B-cells.
Immunodeficiency /
Immunocompromised States
Primary
– Intrinsic abnormality of one or more components of the
Immune System
• >150 Conditions Characterised
• Individually, uncommon, but important to recognise
• Range from global, overwhelming immune failure ( SCID) to subtle
defects in individual components of function
• 1/ 10,000 live births
• Look for infections that are:
Frequent
Suspecting
Immunodeficiency
Recurrent/chronic
Unusual organisms: aspergillous, nocardia
Organisms that respond poorly to therapy
Unusual site: liver abcess, brain abcess
Severity of infection
The Ten Warning Signs of Primary Immunodeficiency
1
8 or more ear infections
within 1 year
Recurrent, deep skin or
organ abscesses
2
2 or more serious sinus infections
within 1 year
Persistent candidiasis
after the age of 1 year
7
3
2 or more months on
antibiotics without resolution
Need for I.V. antibiotic to
clear infections
8
4
2 or more pneumonias
within 1 year
2 or more deep-seated
infections
9
5
Failure to gain weight or grow
normally
A family history of
Primary Immunodeficiency
6
10
Classification of Primary Immunodeficiency
1. Antibody
2.
deficiencies
Cellular deficiencies
3. Phagocytic disorders
4. Complement deficiencies
5. Combined
Immunodeficiencies
HUMORAL Immunodeficiencies
(B-cell defects)
Antibody deficiencies include:
Common
variable immunodeficiency (CVID)
X-linked agammaglobulinemia (XLA)
Selective IgA deficiency (SIgAd)
Selective IgG subclass deficiency (SIgGsd)
Hyper IgM syndrome (HIgM)
Transient hypogammaglobulinemia of Infancy (THI)
Functional antibody deficiency
Early B-cell differentiation .
Lesions can occur at any site in the pathway of B-cell development.
B-cell defect could be in any level in the pathway
B-cell Defect
Onset after maternal antibodies diminish
Usually after 5-7 m/o, later childhood to
adulthood
Bacteria: pneumococci, staphylococci,
Hemophilus, campylobacter, mycoplasma
Virus: entovirus
Recurrent sinopulmonary infections, chronic
GI symptoms, malabsorptions, arthritis,
entroviral meningoencephalitis
X-linked agammaglobulinaemia(bruton)
In X-LA early maturation of B cells fails
Affect males
Few or no B cells in blood
Very small lymph nodes and tonsils
No Ig
Recurrent pyogenic infection
IgA deficiency
Serum IgA level < 10 mg/dl
Prevalence :1:700 , the most common PID
Most are asymptomatic , but have Increased rate of
respiratory tract infection (R.T.I )
Some have recurrent
Symptoms
G.I.T. , Urogenital tract
Because of lack of secretion of IgA on the mucous
membrane of GIT and respiratory tract
Increased incidence of allergic and autoimmune
diseases
Anti - convlusant drugs (phenytoin) may cause
secondary deficiency
2- IgA and IgG subclass defeciency
About 20% lack IgG2and IgG4
Susceptible to pyogenic infection
Result from failure in terminal
differentiation of B cells
3- Immunodfeiciency with increased IgM (HIgM)
Low or absent levels of IgA, IgG , IgE
Production of large amount of IgM >200mg/dl
of polyclonal IgM
Susceptible to pyogenic infection
Due to inability of B cells to isotype switching
They have B cell
4- Common Variable Immunodeficiency (CVID)
There are defect in T cell signaling to B cells
Acquired agammaglobulinemia in the 2nd or 3rd
decade of life
Pyogenic infection
80% of patients have B cells that are not
functioning
B cells are not defective but donot
differentiate into immunoglobulin producing
cell and fail to receive signaling from T
lymphocytes
Risk of autoimmune disease and malignancy
5- Hypogamaglobulinaemia of infancy
Due to delay in in IgG synthesis
approximately up to 36 months
In normal infants synthesis begins at 3
months
Normal B lymphocytes
Probably lack help of T lymphocytes
Immunoglobulin Levels vs. Age
Cellular Immunodeficiencies
Cellular deficiencies include:
Combined immunodeficiency (CID)
Severe combined immunodeficiency (SCID)
Ataxia-Telangiectasia syndrome (AT)
Wiskott-Aldrich syndrome (WAS)
DiGeorge syndrome
Chronic mucocutaneous candidiasis (CMCC)
DiGeorge's syndrome
It the most understood T-cell immunodeficienc
Also known as congenital thymic aplasia/hypoplasia
Associated with hypoparathyroidism, congenital
heart disease, fish shaped mouth.
Defects results from abnormal development of
fetus during 6th-10th week of gestation when
parathyroid, thymus, lips, ears and aortic arch are
being formed
Combined T & B
Immunodeficiencies
SEVERE COMBINED IMMUNODEFICENCY
In about 50% of SCID patients the immunodeficiency is xlinked whereas in the other half the deficiency is
autosomal.
Early onset( 2-6 m/o)
Lymphopenia((< 2500 in infants)
They are both characterized by an absence of T cell and
B cell immunity and absence (or very low numbers) of
circulating T .
Very small thymus, no lymph node , no tonsil
Patients with SCID are susceptible to a variety of
bacterial, viral, mycotic and protozoan infections.
The x-linked SCID is due to a defect in gammachain of IL-2 also shared by IL-4, -7, -11 and
15, all involved in lymphocyte proliferation
and/or differentiation.
The autosomal SCIDs arise primarily from
defects in adenosine deaminase (ADA) or
purine nucleoside phosphorylase (PNP) genes
which results is accumulation of dATP or dGTP,
respectively, and cause toxicity to lymphoid
stem cells
Ataxia-telangiectasia
A complex of immunologic, neurologic, endocrinologic,
hepatic and cutaneous abnormalities
ataxia(10-12y/o) ,telangiectasis (3-6 y/o)
Mutation in ATM gene
T-cells and their functions are reduced to various
degrees.
B cell numbers are normal to low.
Low levels of IgA, IgE, high level of IgM
There is a high incidence of malignancy, particularly
lymphoreicular & adenocarcinoma
Wiskott-Aldrich syndrome
(immunodeficiency with thrombocytopenia and eczema)
X-linked xp11.22-11.23
WASP ; assemby of actin filaments required for
microvesicle formation downstream of protein
kinase C and tyrosine kinase signaling
Low plaletlet, small size platelet
Associated with normal T cell numbers with reduced
functions, which get progressively worse.
IgM concentrations are reduced but IgG levels
are normal
Both IgA and IgE levels are elevated.
Boys with this syndrome develop severe
eczema,bleeding tendency
They respond poorly to polysaccharide
antigens and are prone to pyogenic infection.
Defects of the phagocytic
system
• Defects of phagocytic cells (numbers and/or
functions) can lead to increased susceptibility to a
variety of infections.
• Bacteria,fungal infection
• Skin and mucus membrane
Cyclic neutropenia
Autosomal dominant
Mutation in ELA2(neutrophil elastase gene2)
It is marked by low numbers of circulating
neutrophil approximately every three weeks.
The neutropenia lasts about a week during
which the patients are susceptible to
infection. The defect appears to be due to
poor regulation of neutrophil production.
Tx: r-GCSF ( granulocyte stimulating factor)
Severe congenital Neutropenia
(Kostman)
Arrest in promyelocyte stage
Neutrophil count< 200
Mutation ELA2 or HAX1, autosomal recessive
or dominant
Severe infections
20% prone to AML
Tx: r-GCSF
Shwachman Diamond Syndrome
Mutation in SBDS gene
Diarrhea, FTT, malabsorption till 4 m/o
Eczema, recurrent infections
Neutrophil count< 1000, pancytopenia
Risk of AML
Chronic granulomatous disease (CGD)
•
•
•
•
•
Defect in intra cellular killing
Normal chemotaxis, ingestion
Normal neutrophil count
x-linked (65%)& autosomal recessive
CGD is characterized lymphadenopathy, hepatosplenomegaly and chronic draining lymph nodes.
• In majority of patients with CGD, the deficiency is
due to a defect in NADPH oxidase that participate in
phagocytic respiratory burst.
• Infection with catalase positive organism: e coli,
staph areus , fungal , nocardia, serratia
Leukocyte Adhesion Deficiency
LAD1, LAD2,LAD3
Autosomal recessive
Defect in chemotaxis
These molecules are involved in diapedesis and
hence defective neutrophils cannot respond
effectively to chemotactic signals.
Neutrophilia >12,000 , with infection >100,000
Delayed umblical cord separation > 2 wk
They don't have sign of inflammation such as
swelling, warmth or pus formation
Chediak-Higashi syndrome
(granule sorting disorder)
Mutation in lyst gene
Giant granule in cytoplasm of neutrophils
Respiratory burst is normal.
Associated with NK cell defect, platelet and
neurological disorders
•
•
•
•
•
Albinism(oculocutaneous)
Repeated infections
Mild bleeding tendency
Peripheral neuropathy
Prone to hemophagocytic syndrome
Disorders of complement
system
Complement abnormalities also lead to increased
susceptibility to infections.
There are genetic deficiencies of various
components of complement system, which lead to
increased infections.
The most serious among these is the C3
deficiency which may arise from low C3 synthesis
or deficiency in factor I or factor H.
Defect in classic pathway; AUTOIMMUNE
DISEASE
Congenital deficiency of C5, 6, 7, 8: > 50%
MENINGOCOCCAL or GONOCOCCAL
INFECTION( neisseria)
Hyper IgE (Job) syndrome
Autosomal dominant
Symptoms/signs
Coarse facial features/skeletal abnormalities
Recurrent staph infections
Impetigo (resistant)
Pneumonia with pneumatocele formation
Elevated IgE, Eosinophilia, Eczema
PID - treatments
•
•
•
•
•
•
Immunoglobulin replacement
Bone Marrow Transplantation
Gene-based therapies
Antimicrobial management and prophylaxis
Nutritional Support
Patient Support Groups